Neogen Corp (NEOG) stock
NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)
Close on Nov 17, 2026Market cap $2.38BP/E –Yield –
Neogen profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Neogen's profit margin for the twelve months ending Aug 31, 2026 was -6.3%. For fiscal 2026 it was -0.9%, against -122.1% the year before. The highest annual figure on record is 15.9% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | May 31, 2026 | -0.9% | +121.1 |
| FY2025 | May 31, 2025 | -122.1% | −121.0 |
| FY2024 | May 31, 2024 | -1.0% | +1.8 |
| FY2023 | May 31, 2023 | -2.8% | −11.9 |
| FY2022 | May 31, 2022 | 9.2% | −3.8 |
| FY2021 | May 31, 2021 | 13.0% | −1.2 |
| FY2020 | May 31, 2020 | 14.2% | −0.3 |
| FY2019 | May 31, 2019 | 14.5% | −1.3 |
| FY2018 | May 31, 2018 | 15.9% | +3.6 |
| FY2017 | May 31, 2017 | 12.2% | +0.8 |
| FY2016 | May 31, 2016 | 11.4% | −0.5 |
| FY2015 | May 31, 2015 | 11.8% | +0.5 |
| FY2014 | May 31, 2014 | 11.4% | −1.7 |
| FY2013 | May 31, 2013 | 13.1% | +0.9 |
| FY2012 | May 31, 2012 | 12.2% | −1.0 |
| FY2011 | May 31, 2011 | 13.2% | +0.8 |
| FY2010 | May 31, 2010 | 12.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -5.3% | −22.7 |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -5.0% | +266.5 |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -8.0% | −3.1 |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -7.1% | +190.2 |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | 17.4% | +23.2 |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -271.5% | −269.2 |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -4.9% | −4.0 |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -197.3% | −195.8 |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -5.8% | −6.5 |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -2.3% | −4.6 |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -0.9% | −4.6 |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -1.5% | +16.7 |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | 0.7% | −3.3 |
| Q4 FY2023CQ2 2023 | May 31, 2023 | 2.3% | −8.4 |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | 3.8% | −0.5 |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -18.2% | −26.5 |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | 3.9% | −9.4 |
| Q4 FY2022CQ2 2022 | May 31, 2022 | 10.7% | −1.7 |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | 4.2% | −7.2 |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | 8.3% | −5.5 |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | 13.3% | −1.2 |
| Q4 FY2021CQ2 2021 | May 31, 2021 | 12.4% | −2.6 |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | 11.5% | −0.8 |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | 13.8% | −1.3 |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | 14.5% | +0.1 |
| Q4 FY2020CQ2 2020 | May 31, 2020 | 15.0% | +0.6 |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | 12.2% | −1.2 |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | 15.1% | +0.1 |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | 14.4% | −0.8 |
| Q4 FY2019CQ2 2019 | May 31, 2019 | 14.4% | −1.8 |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | 13.4% | −4.1 |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | 15.0% | −2.0 |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | 15.3% | +2.6 |
| Q4 FY2018CQ2 2018 | May 31, 2018 | 16.2% | +3.6 |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | 17.5% | +5.8 |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | 17.0% | +4.7 |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | 12.6% | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | 12.6% | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | 11.6% | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | 12.3% | – |
See a number that looks wrong?